Radioimmunoassay for methadone
Patent 4104367 Issued on August 1, 1978. Estimated Expiration Date: 
October 13, 1996. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
October 13, 1996. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.InventorsAssigneeApplicationNo. 05/731620 filed on 10/13/1976US Classes:436/542, Involving radioactive labeling436/543, INVOLVING PRODUCING OR TREATING ANTIGEN OR HAPTEN436/545, Radioactive label436/804, RADIOISOTOPE (E.G., RADIOIMMUNOASSAY, ETC.)436/815, TEST FOR NAMED COMPOUND OR CLASS OF COMPOUNDS436/816, Alkaloids, amphetamines, and barbiturates530/363, Serum albumin, e.g., BSA, HSA, etc.530/389.8, Binds drug, hapten, hapten-carrier complex, or specifically-identified chemical structure (e.g., theophylline, digoxin, etc.)530/405, Nitrogen containing reactant560/180Polycarboxylic acidExaminersPrimary: Schafer, Richard E.Assistant: Nucker, Christine M. Attorney, Agent or FirmInternational ClassesC07K 16/44 (20060101)G01N 33/94 (20060101) AbstractAn improved immunoassay for methadone is disclosed. The subject radioimmunoassay utilizes a novel antigen, antibody and novel labelled methadone derivatives.Other References
|
| ||||||||||||||
